<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.09545.012</object-id><label>Table 1.</label><caption><p>Proteomics analyses of CTB crosslinked complexes.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.09545.012">http://dx.doi.org/10.7554/eLife.09545.012</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><td/><td/><td colspan="3">In gel</td><td colspan="3">In solution</td></tr></thead><tbody><tr><td>Protein symbol</td><td>Protein name</td><td>Peptide sequences</td><td>% coverage</td><td>Spectral count</td><td>Peptide sequences</td><td>% coverage</td><td>Spectral count</td></tr><tr><td>ITGB4</td><td>Integrin beta-4</td><td>11</td><td>6.5</td><td>14</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>SLC12A2</td><td>Solute carrier family 12 (Sodium/potassium/chloride transporters), member 2 (isoform CRA)</td><td>6</td><td>6.7</td><td>10</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>CD44</td><td>CD44 antigen</td><td>5</td><td>28.6</td><td>7.92</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>PLXNB2</td><td>Plexin-B2</td><td>4</td><td>3</td><td>6</td><td>5</td><td>3.5</td><td>3.00</td></tr><tr><td>CEACAM5</td><td>Carcinoembryonic antigen-related cell adhesion molecule 5</td><td>3</td><td>6.3</td><td>5</td><td>2</td><td>3.2</td><td>4.00</td></tr><tr><td>CTB</td><td>Cholera toxin subunit B</td><td>2</td><td>15.3</td><td>4</td><td>8</td><td>53.2</td><td>113.00</td></tr><tr><td>LY75</td><td>Lymphocyte antigen 75 (isoform 4)</td><td>3</td><td>2.1</td><td>3</td><td>9</td><td>6.3</td><td>11.00</td></tr><tr><td>COPA</td><td>Coatomer subunit alpha</td><td>3</td><td>3</td><td>3</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>SPTB2</td><td>Spectrin beta chain, brain 1</td><td>4</td><td>1.8</td><td>3</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>ITGA6</td><td>Integrin alpha-6 (isoform Alpha-6X1A)</td><td>NA</td><td>NA</td><td>NA</td><td>13</td><td>12.7</td><td>14.83</td></tr><tr><td>EGFR</td><td>Epidermal growth factor receptor (isoform 1)</td><td>NA</td><td>NA</td><td>NA</td><td>12</td><td>11.5</td><td>11.92</td></tr><tr><td>MUC13</td><td>Mucin-13</td><td>NA</td><td>NA</td><td>NA</td><td>6</td><td>15.6</td><td>9.00</td></tr><tr><td>ITGB1</td><td>Integrin beta-1 (isoform Beta-1A)</td><td>NA</td><td>NA</td><td>NA</td><td>7</td><td>9.3</td><td>7.96</td></tr><tr><td>DPP4</td><td>Dipeptidyl peptidase 4</td><td>NA</td><td>NA</td><td>NA</td><td>8</td><td>10.1</td><td>7.00</td></tr><tr><td>CDCP1</td><td>CUB domain-containing protein 1 (isoform 1)</td><td>NA</td><td>NA</td><td>NA</td><td>6</td><td>6.3</td><td>6.99</td></tr><tr><td>PLXNA1</td><td>Plexin-A1</td><td>NA</td><td>NA</td><td>NA</td><td>8</td><td>4.2</td><td>6.98</td></tr><tr><td>SPINT1</td><td>Kunitz-type protease inhibitor 1 (isoform 2)</td><td>NA</td><td>NA</td><td>NA</td><td>6</td><td>11.3</td><td>6.00</td></tr><tr><td>PARP4</td><td>Poly [ADP-ribose] polymerase 4</td><td>NA</td><td>NA</td><td>NA</td><td>6</td><td>3.8</td><td>6.00</td></tr><tr><td>ITGAV</td><td>Isoform 1 of Integrin alpha-V (isoform 1)</td><td>NA</td><td>NA</td><td>NA</td><td>5</td><td>5.1</td><td>5.00</td></tr><tr><td>ATP1B3</td><td>Sodium/potassium-transporting ATPase subunit beta-3</td><td>NA</td><td>NA</td><td>NA</td><td>4</td><td>17.2</td><td>4.97</td></tr><tr><td>PTGFRN</td><td>PTGFRN protein (Fragment)</td><td>NA</td><td>NA</td><td>NA</td><td>6</td><td>10.6</td><td>4.00</td></tr><tr><td>SCARB1</td><td>Scavenger receptor class B member 1 (isoform 1)</td><td>NA</td><td>NA</td><td>NA</td><td>4</td><td>9.3</td><td>4.00</td></tr><tr><td>PGRMC1</td><td>Membrane-associated progesterone receptor component 1</td><td>NA</td><td>NA</td><td>NA</td><td>3</td><td>15.4</td><td>4.00</td></tr><tr><td>DSG2</td><td>Desmoglein-2</td><td>NA</td><td>NA</td><td>NA</td><td>4</td><td>4.4</td><td>4.00</td></tr><tr><td>PVR</td><td>Poliovirus receptor (isoform beta)</td><td>NA</td><td>NA</td><td>NA</td><td>4</td><td>15.7</td><td>4.00</td></tr><tr><td>COPB1</td><td>Coatomer subunit beta</td><td>NA</td><td>NA</td><td>NA</td><td>4</td><td>5.4</td><td>4.00</td></tr><tr><td>PDIA4</td><td>Protein disulfide-isomerase A4</td><td>NA</td><td>NA</td><td>NA</td><td>4</td><td>6.2</td><td>3.00</td></tr><tr><td>ST14</td><td>Suppressor of tumorigenicity 14 protein</td><td>NA</td><td>NA</td><td>NA</td><td>3</td><td>4.9</td><td>3.00</td></tr><tr><td>RP2</td><td>Protein XRP2</td><td>NA</td><td>NA</td><td>NA</td><td>3</td><td>7.4</td><td>3.00</td></tr><tr><td>CA12</td><td>Carbonic anhydrase 12 (isoform 1)</td><td>NA</td><td>NA</td><td>NA</td><td>5</td><td>15.2</td><td>3.00</td></tr><tr><td>EPHA2</td><td>Ephrin type-A receptor 2</td><td>NA</td><td>NA</td><td>NA</td><td>4</td><td>6.7</td><td>3.00</td></tr><tr><td>MFI2</td><td>Melanotransferrin (isoform 1)</td><td>NA</td><td>NA</td><td>NA</td><td>2</td><td>3.5</td><td>3.00</td></tr><tr><td>CD47</td><td>Leukocyte surface antigen CD47 (isoform OA3-293)</td><td>NA</td><td>NA</td><td>NA</td><td>3</td><td>9.6</td><td>3.00</td></tr></tbody></table><table-wrap-foot><fn><p>CTB crosslinked complexes were isolated on streptavidin-agarose. The complexes were eluted from streptavidin-agarose and applied to SDS-PAGE prior to trypsin digest (in-gel) or trypsinized directly on streptavidin-agarose (in-solution). Tryptic fragments were analyzed by LC-MS/MS to identify proteins crosslinked to CTB. This table lists proteins with spectral counts &#8805; 3 that were present in a crosslinked sample but absent from the corresponding control sample.</p></fn></table-wrap-foot></table-wrap>